These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22650647)
1. Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection. Cammarota G; Sanguinetti M; Gallo A; Posteraro B Aliment Pharmacol Ther; 2012 Aug; 36(3):222-30. PubMed ID: 22650647 [TBL] [Abstract][Full Text] [Related]
2. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Cammarota G; Branca G; Ardito F; Sanguinetti M; Ianiro G; Cianci R; Torelli R; Masala G; Gasbarrini A; Fadda G; Landolfi R; Gasbarrini G Clin Gastroenterol Hepatol; 2010 Sep; 8(9):817-820.e3. PubMed ID: 20478402 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Hathroubi S; Servetas SL; Windham I; Merrell DS; Ottemann KM Microbiol Mol Biol Rev; 2018 Jun; 82(2):. PubMed ID: 29743338 [TBL] [Abstract][Full Text] [Related]
4. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326 [TBL] [Abstract][Full Text] [Related]
5. Biofilm and Helicobacter pylori: from environment to human host. García A; Salas-Jara MJ; Herrera C; González C World J Gastroenterol; 2014 May; 20(19):5632-8. PubMed ID: 24914322 [TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture. Vécsei A; Innerhofer A; Graf U; Binder C; Giczi H; Hammer K; Bruckdorfer A; Hirschl AM; Makristathis A J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):65-70. PubMed ID: 21694538 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [TBL] [Abstract][Full Text] [Related]
8. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715 [TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333 [TBL] [Abstract][Full Text] [Related]
10. Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance. Yonezawa H; Osaki T; Kamiya S Biomed Res Int; 2015; 2015():914791. PubMed ID: 26078970 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori Biofilm and New Strategies to Combat it. Moghadam MT; Chegini Z; Khoshbayan A; Farahani I; Shariati A Curr Mol Med; 2021; 21(7):549-561. PubMed ID: 33272177 [TBL] [Abstract][Full Text] [Related]
13. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Fischbach L; Evans EL Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369 [TBL] [Abstract][Full Text] [Related]
15. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens]. Cheng H; Hu FL; Li J Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976 [TBL] [Abstract][Full Text] [Related]
16. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096 [TBL] [Abstract][Full Text] [Related]
17. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Koskenpato J; Färkkilä M; Sipponen P Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090 [TBL] [Abstract][Full Text] [Related]
19. [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]. Hu FL; Cheng H; Zhang XZ; An HJ; Sheng JQ; Lü NH; Xie Y; Chen ZS; Xu JM; Hu NZ; Zheng PY; Zhang L; Zhang LX; Zhang SS; Tao L; Zhang ZY; Cui MH; Yang GB; Wang BM; Jiang K; Yang Q; Gao HJ Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):679-84. PubMed ID: 22781295 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. Tay CY; Windsor HM; Thirriot F; Lu W; Conway C; Perkins TT; Marshall BJ Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1076-83. PubMed ID: 23072648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]